Search This Blog

Thursday, July 2, 2026

Takeda secures exclusive global rights to therapeutics emerging from AI-driven Insilico collab

 

Takeda, Insilico sign up to $600 million AI-driven drug discovery collaboration

  • Takeda secures exclusive global rights to therapeutics emerging from the AI-driven Insilico Medicine collaboration.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)